Nifty
Sensex
:
:
17094.35
57426.92
276.25 (1.64%)
1016.96 (1.80%)

Medical Equipment/Supplies/Accessories

Rating :
51/99

BSE: 531768 | NSE: POLYMED

865.20
30-Sep-2022
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  • 877.10
  • 879.00
  • 859.30
  • 881.70
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  25034
  •  217.25
  •  1078.00
  •  651.10

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 8,294.54
  • 61.05
  • 5
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 8,404.38
  • 0.29%
  • 7.46

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 53.34%
  • 0.00%
  • 11.93%
  • FII
  • DII
  • Others
  • 15.59%
  • 3.10%
  • 16.04%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 13.52
  • 12.14
  • 10.33

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 15.06
  • 12.01
  • 5.29

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 20.16
  • 16.14
  • 16.05

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 36.39
  • 40.64
  • 48.04

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 8.06
  • 7.41
  • 7.83

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 22.25
  • 23.12
  • 27.18

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 22
Jun 21
Var%
Mar 22
Mar 21
Var%
Dec 21
Dec 20
Var%
Sep 21
Sep 20
Var%
Net Sales
248.85
211.94
17.42%
257.52
212.96
20.92%
230.28
203.51
13.15%
223.37
199.63
11.89%
Expenses
202.38
156.60
29.23%
201.77
158.77
27.08%
179.09
145.70
22.92%
172.50
143.11
20.54%
EBITDA
46.47
55.34
-16.03%
55.75
54.19
2.88%
51.19
57.81
-11.45%
50.87
56.52
-10.00%
EBIDTM
18.67%
26.11%
21.65%
25.45%
22.23%
28.40%
22.77%
28.31%
Other Income
4.57
10.28
-55.54%
8.20
8.50
-3.53%
7.13
5.04
41.47%
12.26
3.24
278.40%
Interest
1.21
3.19
-62.07%
1.45
0.00
0
-0.58
4.78
-
0.20
2.77
-92.78%
Depreciation
13.93
12.87
8.24%
13.99
12.54
11.56%
13.59
12.56
8.20%
13.49
11.44
17.92%
PBT
35.89
49.54
-27.55%
48.51
50.14
-3.25%
45.31
45.51
-0.44%
49.43
45.54
8.54%
Tax
9.33
12.60
-25.95%
12.63
12.97
-2.62%
11.33
10.71
5.79%
12.18
10.96
11.13%
PAT
26.56
36.94
-28.10%
35.88
37.17
-3.47%
33.98
34.80
-2.36%
37.25
34.58
7.72%
PATM
10.68%
17.43%
13.93%
17.46%
14.76%
17.10%
16.68%
17.32%
EPS
2.81
3.92
-28.32%
3.77
4.05
-6.91%
3.60
4.00
-10.00%
3.99
3.97
0.50%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Net Sales
960.02
923.06
786.47
687.24
610.83
520.42
455.01
412.26
390.35
322.25
259.75
Net Sales Growth
15.94%
17.37%
14.44%
12.51%
17.37%
14.38%
10.37%
5.61%
21.13%
24.06%
 
Cost Of Goods Sold
368.73
281.60
212.45
170.01
164.86
124.64
116.82
114.12
110.64
83.33
65.53
Gross Profit
591.29
641.47
574.02
517.23
445.97
395.78
338.19
298.14
279.70
238.92
194.23
GP Margin
61.59%
69.49%
72.99%
75.26%
73.01%
76.05%
74.33%
72.32%
71.65%
74.14%
74.78%
Total Expenditure
755.74
708.05
569.98
521.11
479.59
398.46
361.54
324.50
304.27
246.54
206.87
Power & Fuel Cost
-
29.84
25.27
25.62
24.74
19.04
16.78
15.22
13.16
10.75
10.01
% Of Sales
-
3.23%
3.21%
3.73%
4.05%
3.66%
3.69%
3.69%
3.37%
3.34%
3.85%
Employee Cost
-
163.62
141.76
138.76
116.61
99.13
87.26
74.77
64.99
52.79
42.27
% Of Sales
-
17.73%
18.02%
20.19%
19.09%
19.05%
19.18%
18.14%
16.65%
16.38%
16.27%
Manufacturing Exp.
-
172.94
138.87
129.76
121.66
112.98
96.95
85.38
83.50
67.55
55.30
% Of Sales
-
18.74%
17.66%
18.88%
19.92%
21.71%
21.31%
20.71%
21.39%
20.96%
21.29%
General & Admin Exp.
-
32.52
29.26
33.72
29.74
21.22
21.02
16.70
13.97
16.06
8.56
% Of Sales
-
3.52%
3.72%
4.91%
4.87%
4.08%
4.62%
4.05%
3.58%
4.98%
3.30%
Selling & Distn. Exp.
-
15.68
13.80
15.37
15.89
13.98
17.02
12.88
14.28
10.00
8.42
% Of Sales
-
1.70%
1.75%
2.24%
2.60%
2.69%
3.74%
3.12%
3.66%
3.10%
3.24%
Miscellaneous Exp.
-
11.86
8.57
7.87
6.10
7.48
5.70
5.42
3.72
6.07
8.42
% Of Sales
-
1.28%
1.09%
1.15%
1.00%
1.44%
1.25%
1.31%
0.95%
1.88%
6.46%
EBITDA
204.28
215.01
216.49
166.13
131.24
121.96
93.47
87.76
86.08
75.71
52.88
EBITDA Margin
21.28%
23.29%
27.53%
24.17%
21.49%
23.43%
20.54%
21.29%
22.05%
23.49%
20.36%
Other Income
32.16
37.90
18.41
18.46
18.48
14.38
13.53
8.27
8.12
1.05
0.28
Interest
2.28
6.16
10.64
20.48
13.75
11.58
8.67
9.95
10.25
9.47
7.14
Depreciation
55.00
53.95
47.52
40.53
37.29
29.24
23.73
21.03
18.77
14.05
12.97
PBT
179.14
192.80
176.74
123.58
98.68
95.51
74.60
65.04
65.17
53.23
33.05
Tax
45.47
48.74
44.18
29.85
34.68
26.16
20.06
17.57
23.10
19.12
9.78
Tax Rate
25.38%
25.28%
25.00%
24.15%
35.14%
27.39%
26.89%
27.01%
27.26%
30.28%
29.59%
PAT
133.67
146.51
135.87
93.74
64.00
69.35
54.54
47.47
61.65
44.03
23.35
PAT before Minority Interest
133.67
146.51
135.87
93.74
64.00
69.35
54.54
47.47
61.65
44.03
23.28
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.07
PAT Margin
13.92%
15.87%
17.28%
13.64%
10.48%
13.33%
11.99%
11.51%
15.79%
13.66%
8.99%
PAT Growth
-6.84%
7.83%
44.94%
46.47%
-7.71%
27.15%
14.89%
-23.00%
40.02%
88.57%
 
EPS
13.94
15.28
14.17
9.77
6.67
7.23
5.69
4.95
6.43
4.59
2.43

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Shareholder's Funds
1,087.48
965.57
434.82
381.37
338.30
271.54
228.63
196.18
146.46
112.46
Share Capital
47.95
47.94
44.12
44.12
44.11
44.11
22.06
22.06
22.03
11.01
Total Reserves
1,038.01
916.84
390.56
336.95
293.77
227.43
206.57
174.12
124.01
101.15
Non-Current Liabilities
62.68
86.76
139.23
118.99
103.95
71.56
49.48
55.22
50.68
34.44
Secured Loans
30.56
59.74
114.41
91.38
79.12
47.62
31.06
40.25
38.65
24.17
Unsecured Loans
7.56
3.54
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
3.98
3.27
3.80
3.13
2.10
3.33
2.57
2.04
1.65
1.43
Current Liabilities
226.68
215.10
225.49
181.24
122.58
113.85
109.25
112.62
88.94
67.59
Trade Payables
89.04
64.52
66.36
55.54
43.62
41.86
30.87
39.33
29.71
23.43
Other Current Liabilities
78.57
66.90
72.25
48.99
46.39
39.32
39.89
38.66
38.63
25.11
Short Term Borrowings
58.72
38.82
53.18
45.47
32.24
32.30
33.46
21.05
10.10
13.45
Short Term Provisions
0.35
44.86
33.71
31.24
0.33
0.38
5.03
13.58
10.51
5.60
Total Liabilities
1,376.84
1,267.43
799.54
681.60
564.83
456.95
387.36
364.02
286.08
214.49
Net Block
484.23
421.22
359.49
302.74
261.79
206.07
182.35
165.47
123.09
91.84
Gross Block
818.46
706.56
599.92
507.83
430.48
344.86
298.59
261.15
199.87
156.81
Accumulated Depreciation
334.23
285.34
240.42
205.09
168.69
138.79
116.24
95.68
76.78
64.97
Non Current Assets
593.40
519.62
449.54
352.28
309.62
252.03
216.76
204.51
165.69
120.11
Capital Work in Progress
43.40
21.21
24.71
19.42
18.25
20.00
13.72
9.80
19.66
8.00
Non Current Investment
9.77
9.40
12.92
10.79
10.28
3.92
4.42
3.95
3.43
4.24
Long Term Loans & Adv.
32.25
12.73
19.54
8.82
13.70
17.45
12.89
22.04
17.83
15.04
Other Non Current Assets
19.88
50.54
32.88
10.51
5.60
4.59
3.38
3.25
1.67
0.99
Current Assets
783.44
747.81
350.00
329.32
255.20
204.92
170.60
159.50
120.39
94.38
Current Investments
336.60
345.01
15.92
0.27
10.62
0.00
0.00
0.00
0.00
0.00
Inventories
168.36
126.48
112.09
83.79
72.99
61.95
46.00
57.62
42.01
35.36
Sundry Debtors
206.63
155.86
127.12
128.38
112.54
95.53
82.98
62.81
45.75
43.38
Cash & Bank
15.44
29.56
25.36
54.59
20.39
22.68
21.73
19.98
13.83
0.80
Other Current Assets
56.41
22.01
13.31
21.46
38.66
24.77
19.89
19.09
18.80
14.84
Short Term Loans & Adv.
34.96
68.88
56.20
40.83
16.65
10.29
10.97
9.73
8.95
7.80
Net Current Assets
556.76
532.71
124.51
148.08
132.63
91.07
61.35
46.88
31.45
26.79
Total Assets
1,376.84
1,267.43
799.54
681.60
564.82
456.95
387.36
364.01
286.08
214.49

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Cash From Operating Activity
123.47
118.73
128.30
106.48
74.96
56.07
63.20
63.30
66.14
38.84
PBT
195.24
180.05
125.72
98.68
95.51
74.60
65.04
65.17
53.23
33.05
Adjustment
39.08
44.48
50.59
44.23
39.93
23.28
26.00
42.95
32.92
18.59
Changes in Working Capital
-63.39
-61.19
-12.07
-8.69
-37.35
-23.60
-13.95
-20.96
-2.30
-5.79
Cash after chg. in Working capital
170.93
163.35
164.24
134.21
98.09
74.28
77.09
87.17
83.85
45.85
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-47.46
-44.62
-35.93
-27.72
-23.14
-18.21
-13.89
-23.30
-17.70
-7.01
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-85.33
-435.58
-107.26
-100.74
-88.03
-55.67
-31.38
-59.33
-58.45
-30.63
Net Fixed Assets
-131.05
-100.55
-95.55
-43.89
-82.07
-51.29
-40.24
-48.59
-56.15
-21.81
Net Investments
1.27
-323.40
-15.59
-24.01
-15.56
-0.64
0.00
0.00
1.30
0.00
Others
44.45
-11.63
3.88
-32.84
9.60
-3.74
8.86
-10.74
-3.60
-8.82
Cash from Financing Activity
-35.34
316.95
-20.51
-5.13
15.71
-0.28
-30.77
-5.89
5.39
-8.02
Net Cash Inflow / Outflow
2.80
0.10
0.54
0.62
2.64
0.11
1.06
-1.91
13.09
0.18
Opening Cash & Equivalents
4.95
4.86
4.32
3.70
1.06
0.95
11.86
13.77
0.68
0.57
Closing Cash & Equivalent
7.76
4.95
4.86
4.32
3.70
1.06
12.91
11.86
13.77
0.75

Financial Ratios

Consolidated /

Standalone
Description
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Book Value (Rs.)
113.24
100.62
49.26
43.19
38.30
30.78
25.91
22.24
16.57
12.73
ROA
11.08%
13.15%
12.66%
10.27%
13.58%
12.92%
12.64%
18.97%
17.59%
11.75%
ROE
14.29%
19.42%
22.98%
17.80%
22.76%
21.81%
22.35%
36.03%
34.10%
22.63%
ROCE
17.42%
21.96%
24.43%
22.19%
25.39%
24.37%
25.59%
38.90%
38.77%
26.73%
Fixed Asset Turnover
1.22
1.21
1.24
1.30
1.35
1.44
1.49
1.71
1.83
1.79
Receivable days
71.34
65.34
67.85
71.98
72.79
70.54
63.66
50.14
49.74
53.12
Inventory Days
58.03
55.09
52.02
46.84
47.20
42.65
45.25
46.02
43.18
45.25
Payable days
99.52
112.43
41.75
38.03
38.55
36.95
39.11
41.04
40.10
40.36
Cash Conversion Cycle
29.84
8.01
78.12
80.80
81.45
76.24
69.80
55.12
52.83
58.01
Total Debt/Equity
0.12
0.14
0.47
0.42
0.39
0.37
0.36
0.40
0.46
0.43
Interest Cover
32.68
17.92
7.04
8.18
9.25
9.61
7.54
9.27
7.67
5.63

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.